Publications
For a full list of our publications, please visit PubMed.
- Luo M, Wu S, Huang C, Zheng Z, Xia Q, Li Y, Zhou X, Hong S, Zhong R, Li W et al. Inhibition of PRMT5-dependent YAP methylation attenuates tumorigenicity and radioresistance in glioblastoma. Cancer Lett 2026 Apr 28;644:218308. doi:10.1016/j.canlet.2026.218308
- Yu X, Song X, Schäfer RA, Meng Q, Tiek D, Wu R, He Q, Walker M, Cao Q, Yang R et al. An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs. Nat Cell Biol 2026 Mar 27;. doi:10.1038/s41556-026-01924-w
- Wu R, Yu X, Song X, He Q, Walker M, Sisbarro D, Horbinski C, Tiek D, Hu B, Zhang N et al. Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms. Neuro Oncol 2026 Feb 17;. pii:noag030
- Li Y, Sheng M, Li W, Liu S, Wang B, Liu B, Luo M, Zhou X, Xia Q, Hong S et al. Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. Nat Commun 2025 Dec 13;17(1):440. pii:440
- Song X, Tiek D, Lu M, Yu X, Wu R, Walker M, He Q, Sisbarro D, Hu B, Cheng SY A single-cell atlas of RNA alternative splicing in the glioma-immune ecosystem. Genome Biol 2025 Dec 12;26(1):426. pii:426
- Tiek D, Song X, Wu R, Yu X, Walker M, Mao Y, Sisbarro D, He Q, Magassa A, Singh A et al. Cysteine addiction in drug resistant glioblastoma and therapeutic targeting with designer selenium compounds. Neuro Oncol 2025 Nov 10;. pii:noaf265
- Yu X, Song X, Tiek D, Wu R, Walker M, Horbinski C, Hu B, Cheng SY Targeting PDGFRA-SHP2 signaling enhances radiotherapy in IDH1-mutant glioma. Neuro Oncol 2025 Sep 17;27(8):2023-2034. doi:10.1093/neuonc/noaf086
- Núñez FJ, Banerjee K, Mujeeb AA, Mauser A, Tronrud CE, Zhu Z, Raghuram S, Sheth MR, Agudelo JAP, Zelaya J et al. Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target. Res Sq 2025 Sep 11;. pii:rs.3.rs-7483444
- Wang C, Zhou J, Li T, Du S, Urushidani T, Wang D, Chen Y, Mullen M, Cao X, Cheng SY et al. Akt-elicited phosphorylation of Acapin steers cell migration. J Mol Cell Biol 2025 Sep 10;17(3). pii:mjaf010
- Wu R, Yu S, Bi A, Li Y, Tiek D, Yu K, Xiong H, Shi Q, Mo Z, Yu X et al. Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer. Cancer Lett 2025 Sep 01;627:217823. doi:10.1016/j.canlet.2025.217823
- Cheng SY, Yu X, Song X, Schäfer R, Meng Q, Tiek D, Wu R, He Q, Walker M, Yang R et al. An EGFR Co-Amplified and De Novo Long Noncoding RNA HELDR Promotes Glioblastoma Malignancy through KAT7-Driven Gene Programs. Res Sq 2025 Jun 24;. pii:rs.3.rs-6456987
- Song X, Tiek D, Lu M, Yu X, Wu R, Walker M, He Q, Sisbarro D, Hu B, Cheng SY A Single-Cell Atlas of RNA Alternative Splicing in the Glioma-Immune Ecosystem. bioRxiv 2025 Mar 30;. pii:2025.03.26.645511
- Feng H, Hu B, Vuori K, Sarkaria JN, Furnari FB, Cavenee WK, Cheng S- Correction: EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180. Oncogene 2025 Mar;44(10):710-711. doi:10.1038/s41388-025-03290-7
- Tiek D, Song X, Yu X, Wu R, Iglesia R, Catezone A, McCortney K, Walshon J, Horbinski C, Jamshidi P et al. Oxidative stress induced protein aggregation via GGCT produced pyroglutamic acid in drug resistant glioblastoma. iScience 2025 Feb 21;28(2):111769. pii:111769
- Zhou X, Xia Q, Wang B, Li J, Liu B, Wang S, Huang M, Zhong R, Cheng SY, Wang X et al. USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. Theranostics 2025;15(6):2293-2314. doi:10.7150/thno.103629
- Xu C, Chen G, Yu B, Sun B, Zhang Y, Zhang M, Yang Y, Xiao Y, Cheng SY, Li Y et al. TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA-PKcs. Adv Sci (Weinh) 2024 Aug;11(29):e2400023. pii:2400023
- Song X, Tiek D, Miki S, Huang T, Lu M, Goenka A, Iglesia R, Yu X, Wu R, Walker M et al. RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma. J Clin Invest 2024 Apr 25;134(11). pii:e173789
- Kim DR, Orr MJ, Yu X, Munshi HH, Wang A, Trudeau C, Kwong AJ, Cheng SY, Scheidt KA Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS Med Chem Lett 2024 Feb 08;15(2):258-264. doi:10.1021/acsmedchemlett.3c00505
- Bhutada I, Khambati F, Cheng SY, Tiek DM, Duckett D, Lawrence H, Vogelbaum MA, Mo Q, Chellappan SP, Padmanabhan J CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity. Neuro Oncol 2024 Jan 05;26(1):70-84. doi:10.1093/neuonc/noad143
- Sun MA, Yang R, Liu H, Wang W, Song X, Hu B, Reynolds N, Roso K, Chen LH, Greer PK et al. Repurposing Clemastine to Target Glioblastoma Cell Stemness. Cancers (Basel) 2023 Sep 18;15(18). pii:4619
- Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, Horbinski C, Zhang W, Hu B, Cheng SY Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. Neuro Oncol 2023 Sep 05;25(9):1592-1604. doi:10.1093/neuonc/noad065
- Zeng C, Song X, Zhang Z, Cai Q, Cai J, Horbinski C, Hu B, Cheng SY, Zhang W Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis. Acta Neuropathol Commun 2023 Aug 14;11(1):133. pii:133
- Cai Q, Zhang Z, Cui X, Zeng C, Cai J, Cai J, Wu K, Zhang X, Shi Y, Arvanitakis Z et al. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines. Database (Oxford) 2023 Jun 10;2023. pii:baad042
- Getu AA, Zhou M, Cheng SY, Tan M The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. Cancer Lett 2023 Jun 01;563:216183. doi:10.1016/j.canlet.2023.216183
- Tiek D, Wells CI, Schröder M, Song X, Alamillo-Ferrer C, Goenka A, Iglesia R, Lu M, Hu B, Kwarcinski F et al. SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4. Curr Res Chem Biol 2023;3. pii:100045